Industry News
Research, Science & Manufacturer Updates
Vaccines Articles
A recent study shows two injections of the bacillus Calmette-Guérin (BCG) vaccine a few weeks apart may reverse the causes of type 1 diabetes over several years.
The World Health Organization is recommending a single dose of the typhoid conjugate vaccine (Typbar-TCV) for use in infants and children older than 6 months and a catch-up vaccine in children up to 15 years in countries where the infection is endemic.
Researchers at the TCD School ofMedicine and the National Children’sResearch Centre in Ireland have discovered a distinct immune response in newborns that could lead to both earlier vaccine administration and reduced need for multiple booster shots.
Researchers at the La Jolla Institute for Allergy and Immunology have found individuals who had been inoculated with the newer pertussis (whooping cough) vaccine as part of their initial series of shots mount a weaker recall response when receiving booster shots later on.
The Centers for Disease Control andPrevention is warning about a shortage of Shringrix, the newest shingles vaccine recommended for individuals 50 years and older, due to greater-than-expected demand.
FDA's Vaccines and Related Biological Products Advisory Committee chose the Northern Hemisphere’s 2018-19 influenza (flu) vaccine strains based on the World Health Organization’s recommendations.
An Internet panel survey of healthcare personnel (HCP) showed the overall influenza vaccination coverage estimate among HCP was 78.6 percent in the 2016-17 season, an increase of 15 percentage points since the 2010-11 season, but similar to the 2013-14 through 2015-16 seasons, with the highest coverage among those whose workplace had vaccination requirements.
Grifols’ HyperRAB (rabies immune globulin [human]) has been approved by the U.S. Food and Drug Administration to treat rabies postexposure prophylaxis.
Researchers at the University of Oxford have begun a two-year clinical trial to test a universal influenza (flu) vaccine in more than 2,000 patients.
With many reports about this year’s influenza (flu) vaccine ineffectiveness, a new study shows it is more effective than thought, especially among children.
Scientists at the National Institutes of Health, Frederick National Laboratory for Cancer Research and the University of Melbourne in Australia tested a new universal flu vaccine that produced good immunity against several different strains of influenza viruses.
Researchers at the University of Nottingham in England have found evidence that being in a positive mood when receiving an influenza (flu) vaccine can increase its protective effect.